{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:55:34Z","timestamp":1786992934451,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006662","name":"Ardabil University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jmgm.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T12:35:16Z","timestamp":1527338116000},"page":"138-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation"],"prefix":"10.1016","volume":"83","author":[{"given":"Nima","family":"Razzaghi-Asl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Mirzayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Mahnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saghi","family":"Sepehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2018.05.010_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX-2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2018.05.010_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1212\/WNL.57.6.952","article-title":"Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy","volume":"57","author":"Yasojima","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jmgm.2018.05.010_bib3","first-page":"692","article-title":"Cyclooxygenase inhibitors: a novel direction for Alzheimer's management","volume":"60","author":"Nivsarkar","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jmgm.2018.05.010_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bmcl.2011.01.057","article-title":"Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors","volume":"21","author":"Al-Hourani","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2018.05.010_bib5","doi-asserted-by":"crossref","first-page":"e0134691","DOI":"10.1371\/journal.pone.0134691","article-title":"Computational structure-based De Novo design of hypothetical inhibitors against the anti- inflammatory target COX-2","volume":"10","author":"Dhanjal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2018.05.010_bib6","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.jmgm.2018.05.010_bib7","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1007\/s00044-015-1404-y","article-title":"Design and synthesis of butenolide-based amide derivatives as anti-inflammatory agents","volume":"24","author":"Ali","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2018.05.010_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365528909091168","article-title":"Epidemiology of NSAID-related gastrointestinal side effects","volume":"163","author":"Giercksky","year":"1989","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.jmgm.2018.05.010_bib9","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1007\/s00044-015-1327-7","article-title":"Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring","volume":"24","author":"Abdellatif","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2018.05.010_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.6026\/97320630002325","article-title":"Virtual screening for novel COX-2 inhibitors using the ZINC database","volume":"2","author":"Sudha","year":"2008","journal-title":"Bioinformation"},{"key":"10.1016\/j.jmgm.2018.05.010_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874104501206010015","article-title":"Virtual screening for finding novel COX-2 inhibitors as antitumor agents","volume":"6","author":"Badieyan","year":"2012","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.jmgm.2018.05.010_bib12","first-page":"071","article-title":"Virtual screening for potential COX-inhibiting constituents from Mimosa pudica","volume":"5","author":"Islam","year":"2015","journal-title":"J.\u00a0Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.jmgm.2018.05.010_bib13","first-page":"6","article-title":"Pharmacophore based virtual screening of natural product database to identify potential lead Cyclooxygenase-2 inhibitors (COX-2)","volume":"3","author":"Dhulap","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2018.05.010_bib14","first-page":"338","article-title":"Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in\u00a0vitro studies","volume":"77","author":"Mirza","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2018.05.010_bib15","first-page":"1","article-title":"Anti-HIV-1 activity prediction of novel gp41 inhibitors using structure-based virtual screening and molecular dynamics simulation","volume":"14","author":"Sepehri","year":"2017","journal-title":"Mol. Inform"},{"key":"10.1016\/j.jmgm.2018.05.010_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J.\u00a0Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.jmgm.2018.05.010_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Comp."},{"key":"10.1016\/j.jmgm.2018.05.010_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijmyco.2016.06.020","article-title":"In silico PASS analysis and determination of antimycobacterial, antifungal, and antioxidant efficacies of maslinic acid in an extract rich in pentacyclictriterpenoids","volume":"5","author":"Jamkhande","year":"2016","journal-title":"Int. J. Mycobacteriol"},{"key":"10.1016\/j.jmgm.2018.05.010_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00044-010-9398-y","article-title":"PASS-assisted exploration of new therapeutic potential of natural products","volume":"20","author":"Goel","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2018.05.010_bib20","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00044-017-1893-y","article-title":"Quantum chemical, ADMET and molecular docking studies of ferulic acid amide derivatives with a novel anticancer drug target","volume":"26","author":"Kumar","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2018.05.010_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jmgm.2016.03.001","article-title":"Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor","volume":"65","author":"Nisha","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2018.05.010_bib22","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.05.010_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2018.05.010_bib24","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.05.010_bib25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Spoel","year":"2005","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.05.010_bib26","first-page":"1355","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes, Acta Cryst","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"D\u00a0(Dallas, 1978)"},{"key":"10.1016\/j.jmgm.2018.05.010_bib27","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1080\/07391102.2014.1000377","article-title":"Integrating docking and molecular dynamics approaches for a series of proline-based 2, 5-diketopiperazines as novel \u03b1\u03b2-tubulin inhibitors","volume":"33","author":"Fani","year":"2015","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2018.05.010_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.05.010_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/07391102.2014.892028","article-title":"Computational design of Tryprostatin-A derivatives as novel \u03b1\u03b2-tubulin inhibitors","volume":"33","author":"Fani","year":"2015","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2018.05.010_bib30","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa-a GROMACS tool for high-throughput MMPBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.05.010_bib31","doi-asserted-by":"crossref","first-page":"16719","DOI":"10.1039\/C4CP01388C","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set","volume":"16","author":"Sun","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.05.010_bib32","doi-asserted-by":"crossref","first-page":"22035","DOI":"10.1039\/C4CP03179B","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM\/GBSA and MM\/PBSA rescoring","volume":"16","author":"Sun","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.05.010_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejmech.2014.10.001","article-title":"PASS-assisted design, synthesis and antioxidant evaluation of new butylated hydroxy toluene derivatives","volume":"87","author":"Ariffin","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.05.010_bib34","first-page":"357","article-title":"Screening for human ADME\/Tox drug properties in drug discovery","volume":"6","author":"Li","year":"2001","journal-title":"Res. Focus"},{"key":"10.1016\/j.jmgm.2018.05.010_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.22159\/ajpcr.2017.v10i9.19337","article-title":"Molecular docking and pharmacokinetic prediction of herbal derivatives as maltase glucoamylase inhibitor","volume":"10","author":"Ochieng","year":"2017","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"key":"10.1016\/j.jmgm.2018.05.010_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"Durrant","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.jmgm.2018.05.010_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2017.09.034","article-title":"Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors","volume":"637","author":"Zhou","year":"2017","journal-title":"Gene"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318300974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318300974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:58:57Z","timestamp":1761080337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326318300974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S1093326318300974"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.05.010","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}